Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels

European Journal of Endocrinology

Volumn 163, Issue 2, 2010, Pages 265-272

  Yeap, Bu B ^a,b   Chubb, S A Paul ^a,c   Flicker, Leon ^a,d   McCaul, Kieran A ^d   Ebeling, Peter R ^e   Beilby, John P ^c   Norman, Paul E ^f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; OSTEOCALCIN; TRIACYLGLYCEROL;

AGED; ARTICLE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OSTEOCALCIN; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 77955398568     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0414     Document Type: Article

References (35)

1. Hauschka PV, Lian JB, Cole DE & Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiological Reviews 1989 69 990-1047.
2. Gundberg CM, Nieman SD, Abrams S & Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism 1998 83 3258-3266.
3. Eastell R & Ebeling PR. Bone turnover markers: a key tool for understanding osteoporosis. Osteoporosis International 2009 20 S237-S238.
4. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P & Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007 130 456-469.
5. Ferron M, Hinoi E, Karsenty G & Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. PNAS 2008 105 5266-5270. (Pubitemid 351738545)
6. Im J-A, Yu B-P, Jeon JY & Kim S-H. Relationship between osteocalcin and glucose metabolism. Clinica Chimica Acta 2008 396 66-69.
7. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U & Mellstrom D. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. Journal of Bone and Mineral Research 2009 24 785-791.
8. Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, Hou X, Lu H, Bao Y & Jia W. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. European Journal of Endocrinology 2009 161 723-729.
9. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S & Sugimoto T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 45-49.
10. Fernandez-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gomez-Ambrosi J, Moreno-Navarrete JM, Fruhbeck G, Martinez C, Idoate F, Salvador J, Forga L, Ricart W & Ibanez J. The relationship of serum osteocalcin to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. Journal of Clinical Endocrinology and Metabolism 2009 94 237-245.
11. Pittas AG, Harris SS, Eliades M, Stark P & Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. Journal of Clinical Endocrinology and Metabolism 2009 94 827-832.
12. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporosis International 2007 18 427-444. (Pubitemid 46354916)
13. Khaw K-T, Wareham N, Luben R, Bingham S, Oakes S,Welch A & Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001 322 1-6.
14. Sorkin JD, Muller DC, Fleg JL & Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality. Diabetes Care 2005 28 2626-2632.
15. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC & Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population. Diabetes Care 2007 30 318-324.
16. Saely CH, Aczel S, Marte T, Langer P, Hoefle G & Drexel H. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. Journal of Clinical Endocrinology and Metabolism 2005 90 5698-5703. (Pubitemid 41415478)
17. Moayyeri A, Kaptoge S, Luben RN, Wareham NJ, Bingham S, Reeve J & Khaw KT. Estimation of absolute fracture risk among middle-aged and older men and women: the EPIC-Norfolk population cohort study. European Journal of Epidemiology 2009 24 259-266.
18. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z & Jamrozik K. Cohort Profile: The Health In Men Study (HIMS). International Journal of Epidemiology 2009 38 48-52.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
20. Alberti KGMM, Zimmet P & Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine 2006 23 469-480.
21. Wallace TM, Levy JC & Matthews DR. Use and abuse of HOMA modelling. Diabetes Care 2004 27 1487-1495.
22. Lee NK & Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends in Endocrinology and Metabolism 2008 19 161-166.
23. Kahn SE, Zraika S, Utzschneider KM & Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009 52 1003-1012.
24. Wilson PW, D'Agostino RB, Parise H, Sullivan L & Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 3066-3072.
25. Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H & Eckel RH. The metabolic syndrome. Endocrine Reviews 2008 29 777-822.
26. de Rooij SR, Dekker JM, Kozakova M, Mitrakou A, Melander O, Gabriel R, Guidone C, Hojlund K, Murphy MS, Nijpels G & the RISC Group Investigators . Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. European Journal of Endocrinology 2009 161 223-230.
27. Rothman KJ. Epidemiology: An Introduction, edn 1, ch. 2, pp 8-23. New York: Oxford University Press, 2002.
28. Takahashi M, Kushida K, Nagano A & Inoue T. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clinica Chimica Acta 2000 294 67-76.
29. Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF & Booth SL. g-Carboxylation of osteocalcin and insulin resistance in older men and women. American Journal of Clinical Nutrition 2009 90 1230-1235.
30. Hwang Y-C, Jeong I-K, Ahn KJ & Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes/Metabolism Research and Reviews 2009 25 768-772.
31. Kahn SE, Hull RL & Utzschneider KM. Mechanisms linking besity to insulin resistance and type 2 diabetes. Nature 2006 444 840-846. (Pubitemid 46024990)
32. Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Myers MG, Chua SC, Kim JK, Kaestner KH & Karsenty G. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. Journal of Cell Biology 2008 183 1235-1242.
33. Kawai M, Devlin MJ & Rosen CJ. Fat targets for skeletal health. Nature Reviews. Rheumatology 2009 5 365-371.
34. Leder BZ, Araujo AB, Travison TG & McKinlay JB. Racial and ethnic differences in bone turnover markers. Journal of Clinical Endocrinology and Metabolism 2007 92 3453-3457.
35. Adolphe A, Cook LS & Huang X. A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Mayo Clinic Proceedings 2009 84 221-228.